Cases & Deals

Athersys issues $21 million of Common Stock in public offering

Clients Athersys, Inc.

Jones Day advised Athersys, Inc., a clinical stage biopharmaceutical company, in connection with the issuance of $21 million of Common Stock in a public offering, underwritten by Piper Jaffray & Co. and First Analysis Securities Corporation.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.